Ibuprofen

University of South Australia study finds that common over-the-counter medicines may interact with antibiotics to drive genetic mutations in bacteria, raising fresh concerns for public health.

Anti-inflammatory drug ibuprofen does not worsen COVID-19 symptoms: Study

At the start of the coronavirus pandemic there was concern over the potential effects of non-steroidal anti-inflammatory drugs (NSAIDs), which are used to treat everything from minor pain to chronic arthritis and cardiovascular disease.

Strides Shasun receives USFDA nod for pain reliever

Strides ShasunShasun today said it has received approval from the US health regulator for pain reliever drug ibuprofen.

Will be debt free by end of the year: Vinati Organics

The company has passed on crude price movements to customers, says Vinati Saraf Mutreja, ED of Vinati Organics.

Orange ibuprofen will help strengthen US portfolio: Granules

Granules India gets US FDA approval for orange-coloured 200 mg version of ibuprofen. Speaking to CNBC-TV18, C Krishna Prasad said that the market for orange-coloured tablet is around USD 49 million.

lOL Chemicals up 11%, raises Ibuprofen production capacity

"The company completed its de-bottlenecking/re-engineering project for its Ibuprofen manufacturing facilities at Barnala with project cost of Rs 24 crore and commenced the enhanced production from today," the APIs (active pharmaceutical ingredient) producer said in its filing.

Ibuprofen to add USD 2-4 mn to revenue: Granules India

C Krishna Prasad, Managing Director (MD) of Granules India said with only three to four main competitors in the US market, the company‘s topline and bottomline will benefit from the drug.

Granules India gets USFDA nod for generic Ibuprofen tablets

The Hyderabad-based company said US Food and Drug Administration (USFDA) has approved its abbreviated new drug applications (ANDA) for Ibuprofen tablets in strengths of 400 mg, 600 mg, and 800 mg.

Hope to complete merger formalities by October end: Shasun

Abhaya Kumar, MD at Shasun Pharmaceuticals said the company's merger with Strides will be completed as soon as court approvals of the latter are in place. He is sure the merged entity will be effective from April 1 2015 itself.

India reliant on China for 12 NLEM drugs' ingredients: Govt

"The decision to import and the country of origin for such imports are based on economic considerations, Kumar said.

To clock Rs 1500cr in revenues for 2013-14: Shasun Pharma

Shasun Pharmaceuticals has big capacity expansion plans for 2013-14. Speaking to CNBC-TV18, managing director Abhaya Kumar says the company is planning an investment of more than Rs 250 crore towards achieving this aim.

Ibuprofen may double women's risk of miscarriage: Study

Taking painkillers such as ibuprofen during pregnancy may double a woman's risk of miscarriage, a new study has warned.